1. Home
  2. GKOS vs HII Comparison

GKOS vs HII Comparison

Compare GKOS & HII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$238.12

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Logo Huntington Ingalls Industries Inc.

HII

Huntington Ingalls Industries Inc.

N/A

Current Price

$286.58

Market Cap

10.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
GKOS
HII
Founded
1998
1886
Country
United States
United States
Employees
N/A
44000
Industry
Medical/Dental Instruments
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
10.1B
IPO Year
2015
2010

Fundamental Metrics

Financial Performance
Metric
GKOS
HII
Price
$238.12
$286.58
Analyst Decision
Strong Buy
Buy
Analyst Count
13
12
Target Price
$243.85
★ $357.67
AVG Volume (30 Days)
★ 1.5M
509.1K
Earning Date
10-28-2026
10-29-2026
Dividend Yield
N/A
★ 1.96%
EPS Growth
N/A
★ 10.24
EPS
N/A
★ 14.53
Revenue
$507,442,000.00
★ $12,484,000,000.00
Revenue This Year
$53.82
$9.35
Revenue Next Year
$28.56
$6.22
P/E Ratio
★ N/A
$19.94
Revenue Growth
★ 32.33
8.23
52 Week Low
$93.78
$255.36
52 Week High
$255.19
$460.00

Technical Indicators

Market Signals
Indicator
GKOS
HII
Relative Strength Index (RSI) 59.90 44.57
Support Level $147.72 $281.35
Resistance Level $255.19 $299.84
Average True Range (ATR) 11.84 10.92
MACD -1.49 -2.76
Stochastic Oscillator 43.31 9.62

Price Performance

Historical Comparison
GKOS
HII

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About HII Huntington Ingalls Industries Inc.

Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out from Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships, including amphibious landing ships and Arleigh Burke-class destroyers, while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia- and Columbia-class nuclear submarines. HII shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's mission technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.

Share on Social Networks: